FDA to authorize updated Moderna, Pfizer/BioNTech boosters this week; Planned Parenthood joins suit against Indiana over abortion ban; Advocacy groups sue over copay coupons.
Five things for pharma marketers to know: Tuesday, August 30, 2022
Monkeypox cases may be reaching a peak in U.S.; Biden administration to unveil new COVID-19 booster shot plan after Labor Day; psilocybin may help people with alcohol addiction quit drinking.
Five things for pharma marketers to know: Friday, August 26, 2022
Pfizer says its RSV vaccine protects against severe illness in older adults; Italian man tested positive for COVID-19, monkeypox and HIV on the same day; Investors debate whether Amazon stock is still a buy after Amazon Care folds.
Five things for pharma marketers to know: Thursday, August 25, 2022
CDC guidelines detail how schools should approach monkeypox; Mystery illness is killing dogs in Michigan; Democratic Republic of Congo reports new Ebola case.
Five things for pharma marketers to know: Tuesday, August 23, 2022
White House adds 1.8M doses of monkeypox vax; Biden administration to shift COVID treatment bills to patients, insurers; COVID linked to brain disorders.
Five things for pharma marketers to know: Thursday, August 18, 2022